Search Results

An analysis of final 2021 DAWN data presents: (1) nationally representative weighted estimates, including percent and unadjusted rates per 100,000, for all drug-related ED visits, (2) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (3) the assessment of monthly trends and drugs involved in polysubstance...

Preliminary Findings from Drug-Related Emergency Department Visits, 2021. An analysis of 2021 preliminary data presents (1) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (2) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (3)...

Read key findings from the 2020 National Survey on Drug Use and Health (NSDUH) on substance use, mental health, and treatment by age group. Metrics in the report cover the civilian, noninstitutionalized US population ages 12 and older. Unlike other NSDUH Annual National Reports, the 2020 report has no comparisons...

Read key findings from the 2019 National Survey on Drug Use and Health (NSDUH) on substance use, mental health, and treatment by age group. Metrics in the report cover the civilian, noninstitutionalized US population ages 12 and older. The report covers both current conditions and trends over time.
Along with...

Read key findings from the 2018 National Survey on Drug Use and Health (NSDUH) on substance use, mental health, and treatment by age group. Metrics in the report cover the civilian, noninstitutionalized US population ages 12 and older. The report covers both current conditions and trends over time.

This report summarizes key findings from the 2017 National Survey on Drug Use and Health (NSDUH) for national indicators of substance use and mental health among people aged 12 years old or older in the civilian, noninstitutionalized population of the United States.

This national report summarizes key findings from the 2016 National Survey on Drug Use and Health (NSDUH) for indicators of substance use and mental health among people aged 12 years old or older in the civilian, noninstitutionalized population of the United States. Estimates include tobacco use, alcohol use, illicit drug...

This spotlight uses 2002 to 2014 National Survey on Drug Use and Health to examine trends in past year opioid misuse among adults aged 18 or older by age group.

This spotlight uses the 2015 National Survey on Drug Use and Health to examine the relationship between serious mental illness and past year opioid use among adults aged 18 or older.

This national report summarizes findings from the 2015 National Survey on Drug Use and Health (NSDUH) on trends in the behavioral health of people aged 12 years old or older in the civilian, noninstitutionalized population of the United States. It details the rates and numbers of use of illicit drugs...

This spotlight uses combined 2002 to 2012 National Survey on Drug Use and Health to examine marijuana and pain reliever use among veterans and non-veterans.

This national report summarizes findings from the 2014 National Survey on Drug Use and Health (NSDUH) on trends in the behavioral health of people aged 12 years old or older in the civilian, noninstitutionalized population of the United States. It details the rates and numbers of use of illicit drugs...

This spotlight uses 2013 National Survey on Drug Use and Health to assess race/ethnic differences in the past year nonmedical use of prescription pain relievers among those aged 12 or older.

This is an annual report explaining the Opioid Treatment Program (OTP) survey for 2011. This report represents a census of all SAMHSA-certified OTPs in the United States, both public and private, and presents both highlights and tabular information from the 2011 Opioid Treatment Program (OTP) Survey. The OTP survey was...

This report presents results from the 2012 National Survey on Drug Use and Health (NSDUH). The report includes national estimates of rates of initiation and use of illicit drugs (e.g., marijuana, cocaine, heroin, hallucinogens, inhalants, and the nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, and sedatives), alcohol, and tobacco...